NCT07497841Completed
Development and Validation of a KAP Questionnaire for Secondary Hypertension: Evaluating a Community Short-Video Intervention in Rural Beijing
Development and Application of a KAP Questionnaire for Secondary Hypertension: Evaluating a Community-Targeted Short-Video Intervention in Suburban Beijing
Source: ClinicalTrials.gov · Last updated 27 Mar 2026
Brief summary (registry, in English)
This is a two-phase, non-randomized clinical trial conducted in eight communities in Miyun District, Beijing. The study first develops and validates a reliable 18-item questionnaire (Knowledge, Attitudes, and Practices \[KAP\] scale) to assess community residents' understanding, attitudes, and behaviors related to secondary hypertension. Then, we evaluate whether a 1-week community-centered short-video health education intervention (five 1-minute videos delivered via community WeChat groups by local physicians) can improve residents' secondary hypertension-related knowledge, attitudes, and practices. We will compare scores before and after the intervention, and analyze which groups (such as rural residents, people with lower education, older adults) benefit more. This study aims to provide a simple assessment tool and a scalable health education model for secondary hypertension in community settings, especially for rural and low-educated populations.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 1062 (actual)
- First submitted
- 9 Mar 2026
- Start date
- 1 Dec 2025
- Primary completion date
- 31 Jan 2026
- Lead sponsor
- Peking University First Hospital
- Diseases
- High blood pressure
- NCT number
- NCT07497841
What you commit to
- Study type: Interventional
- Participants enrolled: 1062
- From 1 Dec 2025 to the primary completion date, 31 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior participation in standardized secondary hypertension public education programs
Other illness
- \- Cognitive impairment that would interfere with understanding the questionnaire or video content
Other
- Inability to use WeChat or access short videos (for Phase 2)
Who the study is looking for
- Permanent residents aged ≥18 years with basic comprehension abilities, capable of completing the online questionnaire independently or with assistance
- Voluntary participation and signed informed consent
- For Phase 2 (Intervention Phase) only:
- Individuals with confirmed hypertension or family members cohabiting with hypertensive patients
- Member of a community WeChat group with the ability to receive and view short videos, and to complete online questionnaires independently or with assistance
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Peking University First Hospital Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.